Paul SmithAlexandre Izmailov, Ph.D.
Development and Manufacturing

Dr. Izmailov brings to Axela broad expertise in innovative design and system engineering, nucleic acid technology, and knowledge of manufacturing processes, along with more than 15 years of experience in managing product development in biotechnology companies. Alex was previously Director of Engineering for Visible Genetics Inc., Nucleic Acid Division of Bayer, and Head of Sequencing Systems at Siemens. His responsibilities included development of the instrumentation for molecular diagnostics, transfer to production, and providing engineering support to manufacturing. Alex was deeply involved in the assessment of innovative instrumentation and approaches to DNA sequencing and gene expression analysis including microarray-based technologies. Alex is an author of 23 US Patents, 8 pending patent applications and 11 Russian Patents in laser physics, optics, gel electrophoresis, data processing and microarray devices. Dr. Izmailov received his Ph.D. from St-Petersburg University, Russia.

Back to Management